{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T06:12:15Z","timestamp":1793686335227,"version":"4.5.1"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,1]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Splanchnic vein thrombosis (SVT) refers to Budd\u2013Chiari syndrome (BCS) and portal vein system thrombosis (PVST). Current practice guidelines have recommended the routine screening for antiphospholipid antibodies (APAs) in patients with SVT.<\/jats:p>\n                    <jats:p>A systematic review and meta-analysis of observational studies was performed to explore the association between APAs and SVT.<\/jats:p>\n                    <jats:p>The PubMed, EMBASE, and ScienceDirect databases were searched for all relevant papers, in which the prevalence of positive APAs or levels of APAs should be compared between BCS or noncirrhotic PVST patients versus healthy controls, or between cirrhotic patients with portal vein thrombosis (PVT) versus those without PVT.<\/jats:p>\n                    <jats:p>\n                      Fourteen studies were eligible. Only 1 study evaluated the role of APAs in BCS patients and found that positive immunoglobulin (Ig) G anticardiolipin antibody (aCL) was more frequently observed in BCS patients than in healthy controls; however, the associations of other APAs with BCS were not evaluated. Positive IgG aCL was more frequently observed in noncirrhotic patients with PVST than in healthy controls; however, other APAs, such as IgM aCL, lupus anticoagulants (LAs), anti-\u03b2\n                      <jats:sub>2<\/jats:sub>\n                      -glycoprotein-I antibody (a\u03b2\n                      <jats:sub>2<\/jats:sub>\n                      GPI), and a\u03b2\n                      <jats:sub>2<\/jats:sub>\n                      GPI-oxidized low-density lipoprotein antibody (ox-LDL) were not associated with noncirrhotic PVST. Positive unclassified aCL was more frequently observed in cirrhotic patients with PVT than in those without PVT; however, the association of IgG aCL and IgM aCL with the development of PVT in liver cirrhosis remained inconsistent among studies.\n                    <\/jats:p>\n                    <jats:p>\n                      The risk of BCS and noncirrhotic PVST might be increased by positive IgG aCL but not IgM aCL, LA, a\u03b2\n                      <jats:sub>2<\/jats:sub>\n                      GPI, or a\u03b2\n                      <jats:sub>2<\/jats:sub>\n                      GPI ox-LDL. However, the evidence regarding APAs in BCS originated from only 1 study. The association between APAs and PVT in liver cirrhosis was unclear.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000000496","type":"journal-article","created":{"date-parts":[[2015,1,29]],"date-time":"2015-01-29T02:05:49Z","timestamp":1422497149000},"page":"e496","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":55,"title":["Associations of Antiphospholipid Antibodies With Splanchnic Vein Thrombosis"],"prefix":"10.1097","volume":"94","author":[{"given":"Xingshun","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"De Stefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunping","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiming","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-40-20260903","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11739-010-0413-6","article-title":"Splanchnic vein thrombosis: clinical presentation, risk factors and treatment","volume":"5","author":"De Stefano","year":"2010","journal-title":"Intern Emerg Med"},{"key":"R2-40-20260903","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.thromres.2012.08.259","article-title":"Clinical approach to splanchnic vein thrombosis: risk factors and treatment","volume":"130","author":"Riva","year":"2012","journal-title":"Thromb Res"},{"key":"R3-40-20260903","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/hep.22772","article-title":"Vascular disorders of the liver","volume":"49","author":"DeLeve","year":"2009","journal-title":"Hepatology"},{"key":"R4-40-20260903","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2010.11.006","article-title":"Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee","volume":"43","author":"Senzolo","year":"2011","journal-title":"Dig Liver Dis"},{"key":"R5-40-20260903","first-page":"295","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"JTH"},{"key":"R6-40-20260903","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMra002974","article-title":"The antiphospholipid syndrome","volume":"346","author":"Levine","year":"2002","journal-title":"N Engl J Med"},{"key":"R7-40-20260903","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.autrev.2013.11.004","article-title":"Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis","volume":"13","author":"Reynaud","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R8-40-20260903","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1160\/TH13-06-0509","article-title":"Anti-prothrombin (aPT) and anti-phosphatidylserine\/prothrombin (aPS\/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review","volume":"111","author":"Sciascia","year":"2014","journal-title":"Thromb Haemost"},{"key":"R9-40-20260903","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood-2002-02-0441","article-title":"Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature","volume":"101","author":"Galli","year":"2003","journal-title":"Blood"},{"key":"R10-40-20260903","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0140-6736(98)10362-8","article-title":"Antiphospholipid antibodies and thrombosis","volume":"353","author":"Greaves","year":"1999","journal-title":"Lancet"},{"key":"R11-40-20260903","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1191\/096120398678919688","article-title":"Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis","volume":"7","author":"Wahl","year":"1998","journal-title":"Lupus"},{"key":"R12-40-20260903","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1182\/blood-2011-03-340232","article-title":"Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study","volume":"118","author":"Pengo","year":"2011","journal-title":"Blood"},{"key":"R13-40-20260903","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1160\/TH04-12-0839","article-title":"Antibody profiles for the diagnosis of antiphospholipid syndrome","volume":"93","author":"Pengo","year":"2005","journal-title":"Thromb Haemost"},{"key":"R14-40-20260903","first-page":"237","article-title":"Clinical course of high-risk patients diagnosed with antiphospholipid syndrome","volume":"8","author":"Pengo","year":"2010","journal-title":"JTH"},{"key":"R15-40-20260903","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/01.meg.0000059140.68845.74","article-title":"Anticardiolipin antibodies in chronic hepatitis B and chronic hepatitis D infection, and hepatitis B-related hepatocellular carcinoma. Relationship with portal vein thrombosis","volume":"15","author":"Elefsiniotis","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R16-40-20260903","first-page":"736","article-title":"Serum cardiolipin antibodies in patients with alcoholic cirrhosis","volume":"20","author":"Gervais","year":"1996","journal-title":"Gastroenterol Clin Biol"},{"key":"R17-40-20260903","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00004836-200001000-00013","article-title":"The role of natural anticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis","volume":"30","author":"Egesel","year":"2000","journal-title":"J Clin Gastroenterol"},{"key":"R18-40-20260903","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1038\/ajg.2012.231","article-title":"Extrahepatic portal venous system thrombosis in recurrent acute and chronic alcoholic pancreatitis is caused by local inflammation and not thrombophilia","volume":"107","author":"Rebours","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R19-40-20260903","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1572-0241.1998.00286.x","article-title":"Significance of elevated IgG anticardiolipin antibody levels in patients with Budd\u2013Chiari syndrome","volume":"93","author":"Aggarwal","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"R20-40-20260903","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/1076029610369797","article-title":"Antiphospholipid antibodies and antiphospholipid syndrome: role in portal vein thrombosis in patients with and without liver cirrhosis","volume":"17","author":"Amitrano","year":"2011","journal-title":"Clin Appl Thromb Hemost"},{"key":"R21-40-20260903","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jhep.2004.01.001","article-title":"Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis","volume":"40","author":"Amitrano","year":"2004","journal-title":"J Hepatol"},{"key":"R22-40-20260903","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1572-0241.2001.03465.x","article-title":"High prevalence of thrombophilic genotypes in patients with acute mesenteric vein thrombosis","volume":"96","author":"Amitrano","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R23-40-20260903","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1055\/s-2002-33210","article-title":"Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients: role of genetic thrombophilia","volume":"34","author":"Amitrano","year":"2002","journal-title":"Endoscopy"},{"key":"R24-40-20260903","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0168-8278(00)80842-9","article-title":"Inherited trombophilic disorders in patients with portal vein thrombosis","volume":"32","author":"Amitrano","year":"2000","journal-title":"J Hepatol"},{"key":"R25-40-20260903","first-page":"89","article-title":"Antiphospholipid antibodies and lipoprotein (a) as etiologic or contributory factors in patients with idiopathic cavernous transformation of portal vein","volume":"13","author":"Egesel","year":"2002","journal-title":"Turk J Gastroenterol"},{"key":"R26-40-20260903","first-page":"124","article-title":"Anticardiolipin antibodies in children with portal vein thrombosis","volume":"44","author":"Gulcan","year":"2009","journal-title":"Turk Pediatri Arsivi"},{"key":"R27-40-20260903","first-page":"1527","article-title":"Portal vein thrombosis in cirrhotics: related with anticardiolipin antibodies?","volume":"50","author":"Oksuzoglu","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"R28-40-20260903","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00004836-200010000-00011","article-title":"Antiphospholipid antibodies are related to portal vein thrombosis in patients with liver cirrhosis","volume":"31","author":"Romero Gomez","year":"2000","journal-title":"J Clin Gastroenterol"},{"key":"R29-40-20260903","first-page":"550","article-title":"Increased rate of thrombin generation in hepatitis C virus cirrhotic patients. Relationship to venous thrombosis","volume":"43","author":"Violi","year":"1995","journal-title":"J Investig Med"},{"key":"R30-40-20260903","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/bmj.309.6949.239","article-title":"Relation between lupus anticoagulant and splanchnic venous thrombosis in cirrhosis of the liver","volume":"309","author":"Violi","year":"1994","journal-title":"BMJ"},{"key":"R31-40-20260903","first-page":"47","article-title":"Functional protein C and anti-cardiolipin antibody in children with portal vein thrombosis","volume":"20","author":"Yachha","year":"2001","journal-title":"Indian J Gastroenterol"},{"key":"R32-40-20260903","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jhep.2009.03.013","article-title":"Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development","volume":"51","author":"Zocco","year":"2009","journal-title":"J Hepatol"},{"key":"R33-40-20260903","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.cgh.2014.04.026","article-title":"Associations of coagulation factor V Leiden and prothrombin G20210A mutations with Budd\u2013Chiari syndrome and portal vein thrombosis: a systematic review and meta-analysis","volume":"12","author":"Qi","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R34-40-20260903","doi-asserted-by":"crossref","first-page":"E480","DOI":"10.1111\/hepr.12348","article-title":"Methylenetetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia in Budd\u2013Chiari syndrome and portal vein thrombosis: a systematic review and meta-analysis of observational studies","volume":"44","author":"Qi","year":"2014","journal-title":"Hepatol Res"},{"key":"R35-40-20260903","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/jgh.12085","article-title":"Prevalence of inherited antithrombin, protein C, and protein S deficiencies in portal vein system thrombosis and Budd\u2013Chiari syndrome: a systematic review and meta-analysis of observational studies","volume":"28","author":"Qi","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"R36-40-20260903","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1365-2036.2011.04627.x","article-title":"Meta-analysis: the significance of screening for JAK2V617F mutation in Budd\u2013Chiari syndrome and portal venous system thrombosis","volume":"33","author":"Qi","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"R37-40-20260903","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/gut.49.6.852","article-title":"Antiphospholipid antibodies associated with alcoholic liver disease specifically recognise oxidised phospholipids","volume":"49","author":"Rolla","year":"2001","journal-title":"Gut"},{"key":"R38-40-20260903","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0022-2143(98)90096-8","article-title":"Prevalence of antiphospholipid antibodies in patients with chronic liver disease related to alcohol or hepatitis C virus: correlation with liver injury","volume":"131","author":"Biron","year":"1998","journal-title":"J Lab Clin Med"},{"key":"R39-40-20260903","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/01.meg.0000059144.68845.61","article-title":"Anticardiolipin antibodies in chronic viral hepatitis. Do they have clinical consequences?","volume":"15","author":"Yuste","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R40-40-20260903","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/hep.510230201","article-title":"Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome","volume":"23","author":"Prieto","year":"1996","journal-title":"Hepatology"},{"key":"R41-40-20260903","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1128\/CDLI.7.2.241-244.2000","article-title":"Anticardiolipin antibodies in patients with chronic hepatitis C virus infection: characterization in relation to antiphospholipid syndrome","volume":"7","author":"Ordi-Ros","year":"2000","journal-title":"Clin Diagn Lab Immunol"},{"key":"R42-40-20260903","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1111\/j.1572-0241.1999.01447.x","article-title":"Anticardiolipin antibodies in patients with liver disease","volume":"94","author":"Mangia","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"R43-40-20260903","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s005350050345","article-title":"High prevalence of anticardiolipin antibodies in hepatitis C virus infection: lack of effects on thrombocytopenia and thrombotic complications","volume":"35","author":"Harada","year":"2000","journal-title":"J Gastroenterol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00005792-201501040-00040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:01:01Z","timestamp":1788458461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005792-201501040-00040"}},"subtitle":["A Systematic Review With Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000000496","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1]]}}}